Cite
HARVARD Citation
Fargnoli, M. et al. (2021). Brodalumab for the treatment of moderate‐to‐severe plaque‐type psoriasis: a real‐life, retrospective 24‐week experience. Journal of the European Academy of Dermatology and Venereology. pp. 693-700. [Online].